Delivery Order SPE2DB24D3015-SPE2DB25FGARD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) on September 18, 2025, with completion targeted for October 9, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken and is part of the...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets in quantities of 120s. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract is scheduled for completion by September 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $9,728.17 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Venclexta 100 mg tablets (120-count units). This is a firm fixed-price contract with an ultimate completion date of October 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract is to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $9.73K delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Venclexta 100 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance to be completed by October 3, 2025, and fulfillment occurring at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-count units) with a completion date of September 16, 2025. This competitive award, issued on August 25, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,728.17 for Venclexta 100 mg tablets (120-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and represents a routine pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) valued at $9,728.17. This firm fixed-price delivery order, awarded on June 16, 2025, represents fulfillment under the company's larger pharmaceutical supply contract with DLA. The award was made through open competition with no set-aside designation, with ultimate completion scheduled for July 9, 2025. AmerisourceBergen will fulfill this order from its...
- The Defense Logistics Agency awarded a $9,728.17 delivery order to AmerisourceBergen Drug Corp for Venclexta 100 mg tablets (120-count units) under a firm fixed-price contract. The order, issued on August 19, 2025, with completion targeted for September 10, 2025, represents a direct procurement of this specialized pharmaceutical product to support federal medical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Venclexta 100 mg tablets (120-count units) valued at $9,728.17, with a completion date of October 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a continuation of the company's pharmaceutical supply services to the federal government. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-unit bottles). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by October 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGARDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) under a firm fixed-price contract. The order is scheduled for completion by September 11, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This is an unset-aside, competitively awarded contract that reflects the contractor's established capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio with the DLA focused on delivering essential pharmaceutical products across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 8/20/25 |